help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basset, F.
Right arrow Articles by Crystal, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basset, F.
Right arrow Articles by Crystal, R. G.

American Journal of Pathology, Vol 122, 443-461, Copyright © 1986 by American Society for Investigative Pathology


REGULAR ARTICLES

Intraluminal fibrosis in interstitial lung disorders

F Basset, VJ Ferrans, P Soler, T Takemura, Y Fukuda and RG Crystal

The histopathologic and ultrastructural features of intraluminal organizing and fibrotic changes were studied in open lung biopsies and autopsy specimens from 373 patients with interstitial lung disorders, including hypersensitivity pneumonitis (n = 44), idiopathic pulmonary fibrosis (n = 92), collagen-vascular diseases (n = 20), chronic eosinophilic pneumonia (n = 10), pulmonary histiocytosis X (n-90), pulmonary sarcoidosis (n = 62), pneumoconioses (n = 25), Legionnaire's disease (n = 5), drug- and toxin-induced pneumonitis (n = 4), radiation- induced pneumonitis (n = 2), lymphangioleiomyomatosis (n = 11), and chronic organizing pneumonia of unknown cause (n = 8). Three patterns of intraluminal organization and fibrosis were recognized: 1) intraluminal buds, which partially filled the alveoli, alveolar ducts and/or distal bronchioles; 2) obliterative changes, in which loose connective tissue masses obliterated the lumens of alveoli, alveolar ducts or distal bronchioles, and 3) mural incorporation of previously intraluminal connective tissue masses, which fused with alveolar, alveolar ductal, or bronchiolar structures and frequently became reepithelialized. All three patterns had common morphologic features, suggesting that, regardless of their severity, they resulted from a common pathogenetic mechanism, ie, the migration of activated connective tissue cells, through defects in the epithelial lining and its basement membrane, from the interstitial into the intraluminal compartment. Intraluminal buds were observed most frequently in hypersensitivity pneumonitis, chronic eosinophilic pneumonia, and organizing pneumonia of unknown cause. Mural incorporation and, to a lesser extent, obliterative changes were observed in most interstitial disorders and were very prominent in idiopathic pulmonary fibrosis. Mural incorporation and obliterative changes play an important role in pulmonary remodeling, especially when several adjacent alveoli and/or other air spaces are involved. Under these circumstances, intraluminal organization can mediate the fusion of adjacent alveolar structures by intraluminal connective tissue.


This article has been cited by other articles:


Home page
ChestHome page
J. W. Huh, D. S. Kim, Y.-M. Oh, T. S. Shim, C. M. Lim, S. D. Lee, Y. Koh, W. S. Kim, W. D. Kim, and K. R. Kim
Is Metalloproteinase-7 Specific for Idiopathic Pulmonary Fibrosis?
Chest, May 1, 2008; 133(5): 1101 - 1106.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. M. Strieter
What Differentiates Normal Lung Repair and Fibrosis?: Inflammation, Resolution of Repair, and Fibrosis
Proceedings of the ATS, April 15, 2008; 5(3): 305 - 310.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. L. Fattman, F. Gambelli, G. Hoyle, B. R. Pitt, and L. A. Ortiz
Epithelial expression of TIMP-1 does not alter sensitivity to bleomycin-induced lung injury in C57BL/6 mice
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L572 - L581.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J.-F. Cordier
Challenges in pulmonary fibrosis {middle dot} 2 : Bronchiolocentric fibrosis
Thorax, July 1, 2007; 62(7): 638 - 649.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
E. Roger Parra, R. Adib Kairalla, C. R. R. de Carvalho, and V. L. Capelozzi
Abnormal deposition of collagen/elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias
Thorax, May 1, 2007; 62(5): 428 - 437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Matsuoka, T. H. Sisson, T. Nishiuma, and R. H. Simon
Plasminogen-Mediated Activation and Release of Hepatocyte Growth Factor from Extracellular Matrix
Am. J. Respir. Cell Mol. Biol., December 1, 2006; 35(6): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. L. Myers and A.-L. A. Katzenstein
Fibroblasts in focus.
Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 623 - 624.
[Full Text] [PDF]


Home page
Eur Respir JHome page
J-F. Cordier
Cryptogenic organising pneumonia.
Eur. Respir. J., August 1, 2006; 28(2): 422 - 446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Matsuyama, M. Watanabe, Y. Shirahama, H. Mitsuyama, I. Higashimoto, M. Osame, and K. Arimura
Discoidin Domain Receptor 1 Contributes to the Survival of Lung Fibroblast in Idiopathic Pulmonary Fibrosis
Am. J. Pathol., March 1, 2006; 168(3): 866 - 877.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. Pardo and M. Selman
Matrix metalloproteases in aberrant fibrotic tissue remodeling.
Proceedings of the ATS, January 1, 2006; 3(4): 383 - 388.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. Ray
Protection of Epithelial Cells by Keratincoyte Growth Factor Signaling
Proceedings of the ATS, October 1, 2005; 2(3): 221 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Matsuyama, M. Watanabe, Y. Shirahama, K.-i. Oonakahara, I. Higashimoto, T. Yoshimura, M. Osame, and K. Arimura
Activation of Discoidin Domain Receptor 1 on CD14-Positive Bronchoalveolar Lavage Fluid Cells Induces Chemokine Production in Idiopathic Pulmonary Fibrosis
J. Immunol., May 15, 2005; 174(10): 6490 - 6498.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. D. Burdick, L. A. Murray, M. P. Keane, Y. Y. Xue, D. A. Zisman, J. A. Belperio, and R. M. Strieter
CXCL11 Attenuates Bleomycin-induced Pulmonary Fibrosis via Inhibition of Vascular Remodeling
Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 261 - 268.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. M. Tager, R. L. Kradin, P. LaCamera, S. D. Bercury, G. S. V. Campanella, C. P. Leary, V. Polosukhin, L.-H. Zhao, H. Sakamoto, T. S. Blackwell, et al.
Inhibition of Pulmonary Fibrosis by the Chemokine IP-10/CXCL10
Am. J. Respir. Cell Mol. Biol., October 1, 2004; 31(4): 395 - 404.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Hattori, S. Mizuno, Y. Yoshida, K. Chin, M. Mishima, T. H. Sisson, R. H. Simon, T. Nakamura, and M. Miyake
The Plasminogen Activation System Reduces Fibrosis in the Lung by a Hepatocyte Growth Factor-Dependent Mechanism
Am. J. Pathol., March 1, 2004; 164(3): 1091 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. Lappi-Blanco, R. Kaarteenaho-Wiik, S. Salo, R. Sormunen, M. Maatta, H. Autio-Harmainen, Y. Soini, and P. Paakko
Laminin-5 {gamma}2 Chain in Cryptogenic Organizing Pneumonia and Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 27 - 33.
[Abstract] [Full Text]


Home page
Eur Respir JHome page
K. Aoshiba, T. Tsuji, and A. Nagai
Bleomycin induces cellular senescence in alveolar epithelial cells
Eur. Respir. J., September 1, 2003; 22(3): 436 - 443.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al.
Idiopathic Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Tian, L. Han, J. Kleidon, and C. Henke
An HSV-TK Transgenic Mouse Model to Evaluate Elimination of Fibroblasts for Fibrosis Therapy
Am. J. Pathol., August 1, 2003; 163(2): 789 - 801.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. H. Choi, H. B. Lee, M. Y. Jeong, Y. K. Rhee, M. J. Chung, Y. G. Kwak, and Y. C. Lee
The Role of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Cryptogenic Organizing Pneumonia*
Chest, May 1, 2002; 121(5): 1478 - 1485.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W.-J. Hu, J. W. Eaton, T. P. Ugarova, and L. Tang
Molecular basis of biomaterial-mediated foreign body reactions
Blood, August 15, 2001; 98(4): 1231 - 1238.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y. Fukuda, H. Mochimaru, Y. Terasaki, M. Kawamoto, and S. Kudoh
Mechanism of Structural Remodeling in Pulmonary Fibrosis
Chest, July 1, 2001; 120(2007): 41S - 43S.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
J V Barbas-Filho, M A Ferreira, A Sesso, R A Kairalla, C R R Carvalho, and V L Capelozzi
Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP)
J. Clin. Pathol., February 1, 2001; 54(2): 132 - 138.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. SUGA, K. IYONAGA, T. OKAMOTO, Y. GUSHIMA, H. MIYAKAWA, T. AKAIKE, and M. ANDO
Characteristic Elevation of Matrix Metalloproteinase Activity in Idiopathic Interstitial Pneumonias
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1949 - 1956.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. V. de Lara, C. Becerril, M. Montano, C. Ramos, V. Maldonado, J. Melendez, D. S. Phelps, A. Pardo, and M. Selman
Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression
Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L950 - L957.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Terasaki, Y. Fukuda, M. Ishizaki, and N. Yamanaka
Increased Expression of Epimorphin in Bleomycin-Induced Pulmonary Fibrosis in Mice
Am. J. Respir. Cell Mol. Biol., August 1, 2000; 23(2): 168 - 174.
[Abstract] [Full Text]


Home page
ThoraxHome page
J.-F. Cordier
Rare diseases bullet 8: Organising pneumonia
Thorax, April 1, 2000; 55(4): 318 - 328.
[Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Hattori, T. H. Sisson, Y. Xu, T. J. Desai, and R. H. Simon
Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung
Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L573 - L579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Lemjabbar, P. Gosset, E. Lechapt-Zalcman, M.-L. Franco-Montoya, B. Wallaert, A. Harf, and C. Lafuma
Overexpression of Alveolar Macrophage Gelatinase B (MMP-9) in Patients with Idiopathic Pulmonary Fibrosis . Effects of Steroid and Immunosuppressive Treatment
Am. J. Respir. Cell Mol. Biol., May 1, 1999; 20(5): 903 - 913.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. LEVI, T. van der POLL, H. ten CATE, B. KUIPERS, B. J. BIEMOND, H. M. JANSEN, and J. W. ten CATE
Differential Effects of Anti-cytokine Treatment on Bronchoalveolar Hemostasis in Endotoxemic Chimpanzees
Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 92 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Caniggia, J. Liu, M. Kuliszewski, A. K. Tanswell, and M. Post
Fetal Lung Fibroblasts Selectively Down-regulate Proteoglycan Synthesis in Response to Elevated Oxygen
J. Biol. Chem., March 22, 1996; 271(12): 6625 - 6630.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society for Investigative Pathology.